Health Force
AI agents for hospital operations that automate administrative and operational workflows within existing systems.
Website: https://www.healthforce.ai/
Cover Block
Publicly reported
| Field | Value |
|---|---|
| Name | Health Force |
| Tagline | AI agents for hospital operations that automate administrative and operational workflows within existing systems [Health Force, retrieved 2026] |
| Headquarters | Barcelona, Spain [Invest in Spain, September 2026] |
| Founded | 2022 [HT World, September 2026] |
| Stage | Seed [HT World, September 2026] |
| Business Model | SaaS |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | Western Europe |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2): Fadi Haddad and Juan Sebastián Suárez Valencia [HT World, September 2026] |
| Funding Label | Seed |
| Total Disclosed Funding | $4,500,000 [HT World, September 2026] |
Links
Publicly reported
- Website: https://www.healthforce.ai/
- LinkedIn: https://at.linkedin.com/company/healthforceai
Summary and Signal
PUBLIC Health Force builds AI agents for hospital operations, and it merits investor attention now because it has paired a fresh seed round with early proof points in live hospital workflows, a harder beachhead than pilot-heavy healthcare software typically shows at this stage [HT World, September 2026] [Forbes Italia, September 2026] [JOY Free Press, September 2026]. Founded in 2022, the company began in Vienna and is now headquartered in Barcelona, with reporting also pointing to an operating presence in Milan and an initial commercial wedge in Italian hospital systems [Invest in Spain, September 2026] [HT World, September 2026] [Konsulteer, retrieved 2026].
The product claim is straightforward: agents log into hospitals' existing systems and complete administrative workflows such as claims, quality reporting, and clinical-trial operations end to end, with no new software or integrations required, while keeping actions logged and under human supervision [Health Force, retrieved 2026]. That positioning matters because the differentiation rests less on analytics or dashboarding and more on execution inside incumbent systems, although most efficiency claims, including six-week deployment and 75 percent to 3 out of 4 case automation, remain company-sourced and should be treated cautiously until independently replicated at additional sites [Health Force, retrieved 2026] [Petra Pavlovic - Orbem | LinkedIn, retrieved 2026].
The founding team has some domain credibility where it counts. Public reporting identifies co-founder and CEO Fadi Haddad as an MD and Assistant Professor in the Department of Leukemia at MD Anderson, while co-founder and Chief AI Officer Juan Sebastián Suárez Valencia is described as a physician, data engineer, and former Chief Data Officer at Teladoc France [Fadi Haddad | UT MD Anderson, retrieved 2026] [HT World, September 2026] [TLD Rocket, September 2026] [Juan Sebastián Suárez Valencia - Co-founder & Chief AI Officer at Health Force | The Org, retrieved 2026].
On financing, Health Force announced a €4.2 million seed round in September 2026, led by LUMO Labs with participation from Step Venture, Next Tier Ventures, Target Global, and Calm/Storm Ventures, and the company is operating on a SaaS model [HT World, September 2026] [Crunchbase, retrieved 2026]. The next 12 to 18 months should clarify whether the current Italian validation can translate into repeatable expansion across Spain, France, and Germany, and whether customer evidence broadens beyond named hospital groups and company-reported case volumes of more than 200,000 annually [Forbes Italia, September 2026] [Konsulteer, retrieved 2026] [Health Force, retrieved 2026].
No independent source found -- Core company identity and financing are corroborated by multiple public sources, but the material operating metrics and several product performance claims in this section rely on company statements or lightly corroborated secondary references.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Seed |
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | Western Europe |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding | Seed, total disclosed approximately $4.5 million |
Company Overview
PUBLIC
Health Force presents a fairly clear company arc in the public record, even if the underlying corporate detail is still thin. Crunchbase lists the company as founded in 2022, while the company website describes an AI software business focused on hospital operations, specifically agents that log into existing hospital systems and complete administrative workflows such as claims, quality reporting, and clinical trial tasks [Crunchbase] [Health Force, retrieved 2026].
The current headquarters appears to be Barcelona, according to Crunchbase, and that aligns with how the company now presents itself publicly [Crunchbase]. On the product side, the website's positioning is notable less for broad platform language than for a narrow operational claim: hospitals do not need new software or integrations for deployment, and the company says its agents work inside systems already in use [Health Force, retrieved 2026].
Chronology is limited but usable. The founding year is 2022 on Crunchbase, and the next confirmed public milestone is the company's seed financing profile, with Crunchbase showing Health Force at the seed stage and the broader public record tying that stage to its first disclosed round in 2026 [Crunchbase]. The website also suggests the company has moved beyond pilot framing into active hospital operations, though the site does not provide a dated corporate timeline beyond product and customer deployment claims [Health Force, retrieved 2026].
One source, partially checked -- Confirmed by Crunchbase and the company website, but chronology and entity-level detail remain partial in the cited public sources.
The Product and the Stack
Public record plus analysis
Health Force is selling a narrow promise, and it is a practical one: software agents that do the administrative work inside hospital systems rather than adding another layer of dashboards on top. The company says its agents log into existing hospital software and complete claims, quality reporting, and clinical trial workflows end to end, with no new software or integrations required [Health Force, retrieved 2026]. Public coverage in September 2026 describes the same core motion, framing the product as AI agents for hospital operations and noting validation in Italian hospitals [HT World, September 2026] [Forbes Italia, September 2026].
The product surface described publicly is department-specific. On its website, Health Force lists Claims & Billing, Quality Reporting, and Trials (beta) as the current agent categories, and says each agent works under human supervision, with every action logged and traceable, while routing exceptions for human judgment [Health Force, retrieved 2026]. That operating model matters in hospital administration, where workflow reliability and auditability often matter as much as raw automation rates. The company's stronger performance claims, including six-week go-live timing, three out of four cases completed with no human touch, and backlog reduction, remain company-reported and should be read as directional until independently corroborated [Health Force, retrieved 2026].
A few customer-side references do give the product more shape, even if they do not amount to a verified technical demo. Health Force's site says it is trusted with daily operations in leading European hospital groups, while external references report deployments or production use at Humanitas Research Hospital and Ospedale Galeazzi, part of Gruppo San Donato [Health Force, retrieved 2026] [Konsulteer] [JOY Free Press, September 2026]. Separate third-party references also repeat the claim that the system handles more than 200,000 patient cases annually in Italy, which suggests the product has moved past pilot framing and into recurring operational use, though the exact counting methodology is still unclear [Petra Pavlovic - Orbem | LinkedIn, retrieved 2026] [Konsulteer] [Madjid Salimi - Co-Founder & Co-CEO of AMBOSS, retrieved 2026].
No independent source found -- This section relies materially on company website claims for product behavior and performance, with partial public corroboration from HT World, Forbes Italia, LinkedIn posts, and secondary coverage.
The Market They Are Entering
PUBLIC
The market matters now because hospitals across Europe are under pressure to reduce administrative drag without adding more software layers or headcount, and Health Force is positioning directly into that constraint set rather than into a discretionary analytics budget [Forbes Italia, September 2026] [Invest in Spain, September 2026] [Health Force, retrieved 2026].
The available public record does not support a clean TAM, SAM, and SOM build for Health Force’s exact category. No named third-party market report in the source set sizes "AI agents for hospital operations" as a standalone segment, so the better approach is to treat hospital workflow automation, revenue-cycle operations, and clinical-administration software as adjacent markets rather than assert a precision that the evidence does not support [HT World, September 2026] [Forbes Italia, September 2026]. That matters because Health Force’s product claims span several budget lines at once: claims and billing, quality reporting, and clinical-trial operations are typically purchased, staffed, and measured differently inside provider organizations, even when the pain point is the same, namely manual work across legacy systems [Health Force, retrieved 2026].
Demand in the cited reporting is driven less by experimental AI spending and more by operational bottlenecks that hospitals already recognize. Health Force says its agents log into existing hospital systems, work under human supervision, and require no new integrations or new software, which suggests a go-to-market aimed at institutions that want throughput gains without a long core-IT replacement cycle [Health Force, retrieved 2026]. Third-party coverage points in the same direction: Forbes Italia reported validation in leading Italian hospitals, while Invest in Spain and HT World tied the seed round to expansion across additional workflows and European markets, implying that the company’s early wedge is administrative execution rather than frontier clinical decision support [Forbes Italia, September 2026] [Invest in Spain, September 2026] [HT World, September 2026].
The nearest substitute markets are robotic process automation for healthcare administration, healthcare revenue-cycle software, quality and compliance reporting tools, and trial-operations software. Health Force appears to sit across those categories with an "agents do the work" pitch rather than a system-of-record pitch, which is commercially attractive if buyers accept software that acts inside incumbent tools instead of replacing them [Health Force, retrieved 2026] [EU-Startups, September 2026]. The tradeoff is that substitute vendors already sell into the same hospital operators, and buyers may compare the product not only against other AI automation tools but also against outsourcing, internal shared-services teams, and narrower point solutions for billing or reporting [EU-Startups, September 2026] [TLD Rocket, September 2026].
Regulation and macro conditions cut both ways, but the public evidence suggests they are more likely to shape implementation speed than eliminate demand. European providers face persistent budget discipline, workforce pressure, and a need for traceability in operational processes, all of which support a supervised-automation narrative if the product can show auditability and controlled exception handling [Health Force, retrieved 2026] [Invest in Spain, September 2026]. At the same time, hospital procurement cycles, data-governance scrutiny, and country-by-country variation in health-system administration can slow expansion, which is relevant because the company has stated ambitions beyond Italy into Germany, France, and Spain [Invest in Spain, September 2026] [HT World, September 2026].
| Market lens | What the public evidence supports | Source |
|---|---|---|
| Core category | Hospital operations automation using AI agents is the company’s stated category | [Health Force, retrieved 2026] |
| Adjacent buying center | Claims and billing workflow automation | [Health Force, retrieved 2026] |
| Adjacent buying center | Quality reporting workflow automation | [Health Force, retrieved 2026] |
| Adjacent buying center | Clinical-trial operations workflow automation | [Health Force, retrieved 2026] |
| Geographic expansion signal | Italy is the reported initial validation market, with expansion plans into Germany, France, and Spain | [Forbes Italia, September 2026] [Invest in Spain, September 2026] |
The table is narrow by design. It shows that the public case rests on budget adjacency and workflow breadth, not on a well-cited market-size slide, which makes early customer proof more important than category storytelling in assessing the opportunity.
One source, partially checked -- This section relies on named third-party reporting for geography, expansion plans, and hospital validation, but category framing and workflow scope still depend partly on company materials.
The Competitive Field
MIXED Health Force is positioning itself less as another hospital software dashboard and more as an execution layer that works inside the systems hospitals already run, which places it closer to services replacement and workflow automation than to classic analytics vendors [Health Force, retrieved 2026] [Forbes Italia, September 2026].
That matters because the practical alternatives are not neatly one set of startup peers. In the first lane sit incumbent hospital IT systems and the internal operations teams built around them, which remain the default option for claims, reporting, and trial-administration work even when those processes are slow or manual; Health Force's pitch is that its agents log into existing systems, complete tasks end to end, and avoid a fresh integration cycle [Health Force, retrieved 2026]. In the second lane sit consulting, BPO, and implementation-heavy approaches, including the Deloitte-assisted route the company reportedly used to win early Italian hospital clients, which suggests the buyer can solve the same problem through labor and process redesign rather than software alone [Konsulteer, retrieved 2026]. In the third lane sit newer AI workflow vendors, but the supplied sources do not name direct startup rivals, so the public record here supports category analysis more than company-by-company ranking.
Health Force's edge, on the evidence available, is a combination of workflow specificity and referenceability in Italy. The company and third-party coverage repeatedly anchor on production use in named hospital environments, including Humanitas Research Hospital and Ospedale Galeazzi of Gruppo San Donato, alongside a recurring claim of 200,000-plus patient cases processed annually [Konsulteer, retrieved 2026] [JOY Free Press, September 2026] [Petra Pavlovic - Orbem | LinkedIn, retrieved 2026]. That is meaningful because hospital operations software often fails at deployment rather than concept. Still, the durability of this edge is not yet clear. If the advantage rests mainly on implementation know-how and hospital-specific workflow tuning, it can compound with each rollout but can also be copied by well-capitalized entrants or consulting-led competitors once the playbook is visible [HT World, September 2026] [Health Force, retrieved 2026].
The company's exposure is easier to identify than its moat. It does not appear, from the public sources provided, to own the core hospital system, the payer relationship, or the procurement channel; it is operating on top of infrastructure controlled by incumbents and entering hospitals through a sales and delivery motion that may remain relatively high touch [Health Force, retrieved 2026] [Konsulteer, retrieved 2026]. That creates two risks. First, incumbent EHR, revenue-cycle, or hospital-administration vendors can respond by adding similar agentic automation into products they already sell. Second, large services firms and systems integrators can bundle workflow automation into broader digital-transformation mandates, where they already have budget authority and trust. Health Force's claim that it requires no new software or integrations is commercially attractive, but it may also limit switching costs if another vendor can make the same promise [Health Force, retrieved 2026].
Over the next 18 months, the most plausible competitive split is between execution vendors that can prove safe production outcomes in live hospitals and those that remain at pilot stage. In that scenario, Health Force is a likely winner if hospital buyers continue to prioritize speed to deployment and auditable automation inside existing systems, because the company already markets around six-week go-live timelines, logged actions, and human-supervised exception handling [Health Force, retrieved 2026]. The likely loser if procurement shifts toward platform consolidation would be standalone workflow entrants without entrenched distribution, because integrated hospital software vendors and consulting-led delivery partners would have the advantage of existing contracts and broader scope. The public evidence does not support naming a direct startup loser here, but it does support the broader point that channel control, not model quality alone, will probably decide the category.
Opportunity
PUBLIC
If Health Force executes, the prize is not a point solution for claims ops, but a cross-workflow automation layer that hospitals trust to do administrative work inside the systems they already run, a position that can become unusually sticky in European healthcare operations [Health Force, retrieved 2026] [Forbes Italia, September 2026] [HT World, September 2026].
The headline opportunity is straightforward. Health Force is trying to sell completed work, not software seats: its agents reportedly log into existing hospital systems, complete claims, quality reporting, and clinical-trial workflows end to end, and do so without requiring new integrations or new software according to the company website [Health Force, retrieved 2026]. That matters because hospital operations budgets often fragment by department and by system, while the pain point is cross-system manual labor. If Health Force can remain credible on deployment speed, with the company claiming go-live in six weeks, and on production performance, with public claims of more than 200,000 patient cases processed annually and daily production at Ospedale Galeazzi, then the business has a plausible path from one workflow wedge into a broader operating layer across hospital administration [Health Force, retrieved 2026] [Konsulteer, retrieved 2026] [JOY Free Press, September 2026].
The public evidence is still early, but it is specific enough to support real upside rather than abstract ambition. Third-party coverage ties the company to named hospital groups including Humanitas and Gruppo San Donato, and multiple independent references repeat the 200,000-plus annual case volume figure in Italy [Konsulteer, retrieved 2026] [Petra Pavlovic - Orbem | LinkedIn, retrieved 2026] [Madjid Salimi - Co-Founder & Co-CEO of AMBOSS, retrieved 2026]. The September 2026 seed round, led by LUMO Labs with participation from Step Venture, Next Tier Ventures, Target Global, and Calm/Storm Ventures, gives the company capital to add more agent types and expand into Germany, France, and Spain, which is the kind of adjacent-market progression this model requires [HT World, September 2026] [EU-Startups, September 2026] [Invest in Spain, September 2026].
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Italy-to-Europe workflow expansion | Health Force starts with claims and adjacent admin tasks in Italian hospital groups, then adds quality reporting and clinical-trial operations before selling the same agent catalog into Spain, France, and Germany | The 2026 seed financing funds expansion of the agent catalog and entry into additional European markets [HT World, September 2026] [Invest in Spain, September 2026] | Public sources already place the product in leading Italian hospitals, and the company presents multiple workflow modules rather than a single-purpose tool [Forbes Italia, September 2026] [Health Force, retrieved 2026] |
| Become the default automation layer for hospital back office teams | Hospitals adopt the platform because it works inside existing systems, reducing the need for rip-and-replace software projects | Continued proof that agents can operate without new integrations and under human supervision with traceable actions [Health Force, retrieved 2026] | The product positioning is unusually aligned with how hospitals buy operations software: low-change implementation, auditability, and workflow completion rather than analytics alone [Health Force, retrieved 2026] [Forbes Italia, September 2026] |
| Multi-hospital enterprise standard | A few large hospital groups standardize on Health Force across departments, turning departmental wins into group-wide deployments | A category-tipping customer reference from groups such as Humanitas or Gruppo San Donato, both publicly associated with the company in current reporting [Konsulteer, retrieved 2026] | The company is already linked to named hospital groups and daily production use at Ospedale Galeazzi, which suggests at least the beginnings of referenceable enterprise trust [Konsulteer, retrieved 2026] [JOY Free Press, September 2026] |
The compounding logic rests on repetition. If one agent can be deployed into an existing hospital system with limited implementation friction, the next sale is not from zero, because the buyer already understands the operating model, governance approach, and supervision layer [Health Force, retrieved 2026]. That creates a practical flywheel: one department proves ROI, adjacent departments adopt additional agents, hospital groups standardize processes, and the company accumulates workflow-specific know-how across claims, reporting, and trial operations. The early signs are modest but visible in public material, with Health Force presenting a multi-agent platform and third-party coverage describing validation in leading Italian hospitals rather than a single pilot site [Health Force, retrieved 2026] [Forbes Italia, September 2026].
There is also a data and process advantage if execution holds. Every logged action inside legacy hospital systems can improve exception handling, escalation patterns, and workflow templates, while the human-supervision model may make buyers more comfortable expanding scope into higher-value processes over time [Health Force, retrieved 2026]. This is not a consumer-style network effect, but it can still compound like infrastructure: faster deployments, more reusable process logic, and stronger procurement credibility once several hospital groups are live. In healthcare operations, that kind of trust can matter as much as model quality.
The size of the win is best framed as a scenario, not a forecast. No credible public market-cap or TAM figure specific to this niche appears in the supplied sources, so the cleaner comparison is strategic importance rather than a forced valuation multiple. If Health Force became the standard automation layer across major European hospital groups for claims, reporting, and trial operations, it could plausibly grow into a platform of strategic value to large healthcare IT, revenue-cycle, or clinical software incumbents (scenario, not a forecast), because it would sit at the workflow execution layer inside existing systems rather than at the dashboard layer [Health Force, retrieved 2026] [HT World, September 2026]. The evidence today supports that as an investable upside case to monitor, particularly because the company already pairs named hospital references with a product thesis that fits the procurement reality of hospitals.
One source, partially checked -- Funding, founders, geography, and expansion plans are supported by named publishers including HT World, EU-Startups, Forbes Italia, and Invest in Spain. Product performance metrics and deployment claims remain partly company-sourced, with partial corroboration from third-party commentary and LinkedIn posts.
Sources
Publicly reported
[Health Force, retrieved 2026] Hire AI Agents for Hospital Operations | Health Force | https://www.healthforce.ai/
[Invest in Spain, September 2026] Austrian AI healthcare company Health Force relocates to Spain | https://www.investinspain.org/en/news/2026/health
[HT World, September 2026] AI agent startup Health Force raises €4.2 million | https://htworld.co.uk/news/ai/ai-agent-startup-health-force-raises-e4-2-million-htai26/
[Forbes Italia, September 2026] Questa startup sta portando l'IA dentro le amministrazioni degli ospedali. Ora ha raccolto 4,2 milioni per crescere in Europa | https://forbes.it/2026/09/17/health-force-round-agenti-ai-ospedali-europa/
[Crunchbase, retrieved 2026] Health Force - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/health-force-e446
[Konsulteer, retrieved 2026] Health Force | https://www.konsulteer.com
[Fadi Haddad | UT MD Anderson, retrieved 2026] Fadi Haddad | UT MD Anderson | https://www.mdanderson.org
[TLD Rocket, September 2026] Health Force nets €4.2M to deploy its AI agents across Europe | https://tldrocket.com/story/health-force-nets-eur42m-to-deploy-its-ai-agents-across-europe
[Juan Sebastián Suárez Valencia - Co-founder & Chief AI Officer at Health Force | The Org, retrieved 2026] Juan Sebastián Suárez Valencia - Co-founder & Chief AI Officer at Health Force | The Org | https://theorg.com
[Petra Pavlovic - Orbem | LinkedIn, retrieved 2026] Petra Pavlovic - Orbem | LinkedIn | https://www.linkedin.com
[EU-Startups, September 2026] Barcelona-based Health Force raises €4.2 million to streamline hospital operations with AI agents | EU-Startups | https://www.eu-startups.com/2026/09/barcelona-based-health-force-raises-e4-2-million-to-streamline-hospital-operations-with-ai-agents/
[JOY Free Press, September 2026] Health Force agents are in daily production at Ospedale Galeazzi | https://joyfreepress.com
[Madjid Salimi - Co-Founder & Co-CEO of AMBOSS, retrieved 2026] Madjid Salimi - Co-Founder & Co-CEO of AMBOSS | https://www.linkedin.com
Articles about Health Force
- Health Force's AI Agents Log Into Hospital Systems to Clear a Backlog — The Barcelona-based startup is using supervised AI to automate insurance claims and quality reporting, starting with a foothold in Italy's largest hospital groups.